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Abstract 47 
Evidence indicates that increases in sympathetic nervous activity (SNA), and acclimatization to 48 
high-altitude (HA), may reduce endothelial function as assessed by brachial artery flow-mediated 49 
dilatation (FMD); however, it is unclear whether such changes in FMD are due to direct vascular 50 
constraint, or consequential altered hemodynamics (e.g. shear stress) associated with increased 51 
SNA as a consequence of exposure to HA. We hypothesized that: 1) at rest, SNA would be 52 
elevated and FMD would be reduced at HA compared to sea-level (SL); and 2) at SL and HA, 53 
FMD would be reduced when SNA was acutely increased, and elevated when SNA was acutely 54 
decreased. Using a novel, randomized experimental design, brachial artery FMD was assessed at 55 
SL (344m) and HA (5050m) in 14 participants during mild lower-body negative pressure 56 
(LBNP; -10 mmHg) and lower-body positive pressure (LBPP; +10 mmHg). Blood pressure 57 
(finger photoplethysmography), heart rate (electrodcardiogram), oxygen saturation (pulse 58 
oximetry), and brachial artery blood flow and shear rate (Duplex ultrasound) were recorded 59 
during LBNP, control, and LBPP trials. Muscle SNA was recorded (via microneurography) in a 60 
subset of participants (n=5). Our findings were: 1) at rest, SNA was elevated (P<0.01), and 61 
absolute FMD was reduced (P=0.024), but relative FMD remained unaltered (P=0.061), at HA 62 
compared to SL, and 2) despite significantly altering SNA with LBNP (+60.3±25.5%) and LBPP 63 
(-37.2±12.7%) (P<0.01), FMD was unaltered at SL (P=0.448), and HA (P=0.537). These data 64 
indicate that acute and mild changes in SNA do not directly influence brachial artery FMD at SL 65 
or HA. 66 
 67 
New and Noteworthy: The role of the sympathetic nervous system on endothelial function 68 
remains unclear. We used lower-body negative and positive pressure to manipulate sympathetic 69 
nervous activity at sea-level and high-altitude, and measured brachial endothelial function via 70 
flow-mediated dilation. We found that acutely altering sympathetic nervous activity had no 71 
effect on endothelial function. 72 
 73 
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Abbreviations: 75 
CO, cardiac output 76 
FMD, flow-mediated dilatation 77 
HR, heart rate 78 
LBNP, lower-body negative pressure 79 
LBPP, lower-body positive pressure 80 
MAP, mean arterial pressure 81 
MSNA, muscle sympathetic nervous activity 82 
SNA, sympathetic nervous activity 83 
SpO2, peripheral oxyhemoglobin saturation 84 
SRAUC, shear rate area under the curve 85 
SV, stroke volume 86 
TPR, total peripheral resistance 87 
 88 
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Introduction 90 
Brachial artery flow-mediated dilatation (FMD) is a non-invasive measurement of artery 91 
diameter changes in response to a transient increase in shear stress, and provides a clinical index 92 
of endothelial function [reviewed in: (48)]. Brachial FMD can be altered by several physiological 93 
factors such as: a) oxidative stress (20, 45); b) shear stress, and hemodynamics [e.g. cardiac 94 
output and blood pressure; (4, 12, 28, 32)]; c) inflammation (24, 27), and; d) sympathetic 95 
nervous system activity SNA) (1, 16, 26, 47, 50, 53). Given that increased SNA has been linked 96 
to cardiovascular disease and aging (8, 31, 37), from a clinical perspective, it is important to 97 
clearly understand the effects of SNA on vascular health in humans. In this context, the role of 98 
SNA on endothelial function has been examined by several investigations in young, healthy 99 
humans. These studies have revealed that FMD is impaired under conditions in which SNA is 100 
acutely elevated, such as lower-body negative pressure (LBNP) (26, 47), cold pressor test (16), 101 
mental stress (19), and immediately after cycling exercise (1, 4, 11, 29, 53). Additionally, 102 
exposure to hypobaric hypoxia (e.g. high-altitude) - which markedly elevates resting SNA (15, 103 
23), has been demonstrated to reduce endothelial function in some (3, 35), but not all cases (5, 6, 104 
52, 53). Differences in the degree and duration of altitude exposure, shear stress stimulus, and 105 
altitude ascent profile (passive vs. active) likely explain these variable findings on the influence 106 
of altitude on endothelial function.  107 
It is clear that SNA is elevated during moderate or severe LBNP (43, 54), cold pressor 108 
test (16, 44), acute and chronic hypoxic exposure (13, 15, 23), and during lower-body cycling 109 
exercise (30). However, in addition to increasing SNA, each of these interventions have 110 
consequential changes in heart rate, stroke volume, blood pressure, and retrograde shear (i.e. 111 
altered hemodynamics) – these physiological factors can directly affect endothelial function (4, 112 
11, 32, 33, 40, 41, 49). Currently, it remains unclear whether the current observed reductions in 113 
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brachial artery endothelial function are directly due to SNA related vascular constraint, or by 114 
physiological consequences of SNA (e.g., increases in retrograde shear rate), which directly 115 
impairs endothelial function (47).  116 
We attempted to address this gap in the literature by investigating the role of SNA on 117 
endothelial function independent of altered hemodynamics using an experimental design similar 118 
to previous work (38), involving mild LBNP (-10 mmHg) and mild lower-body positive pressure 119 
(LBPP; +10 mmHg), which alters both cardiopulmonary and arterial baroreflex activity (38). The 120 
distinct advantage of employing a mild LBNP/LBPP model is that both modalities alter SNA 121 
independent of changes in heart rate (18, 42), stroke volume (18), blood pressure (9, 18, 42), and 122 
brachial artery vessel diameter (41). In supine position at rest, mild LBNP (-5 to -10 mmHg) has 123 
demonstrated to significantly increase SNA by ~30-60% (9, 42, 43), while LBPP (+10 to +20 124 
mmHg) decreases SNA by ~30% (18), in healthy individuals. Interestingly, the elevations in 125 
SNA observed during mild LBNP (~30-60%) are comparable to those achieved with acute 126 
hypoxia (FIO2 = 0.11) (13), which reduces brachial FMD via an α1-adrenergic pathway (35). In 127 
addition, due to SNA withdrawal, the novel approach of using LBPP may serve as a non-128 
pharmacological tool to elevate endothelial function, especially in the presence of hypobaric 129 
hypoxia when resting SNA is markedly elevated (15, 23).  130 
By employing a counter-balanced, randomized design, the primary purposes of the 131 
current study were to investigate the role of the sympathetic nervous activity on endothelial 132 
function at sea-level (344m), and during chronic exposure to hypobaric hypoxia (5050m) where 133 
resting sympathetic nervous activity is chronically elevated (15, 23). By using a novel, purpose 134 
built, light-weight, portable lower-body differential pressure chamber to alter sympathetic 135 
nervous activity largely independent of hemodynamics, we hypothesized that: 1) at rest, 136 
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sympathetic nervous activity would be elevated, and endothelial function would be reduced at 137 
high-altitude compared to sea-level, 2) at sea-level and after acclimatization to high-altitude, 138 
endothelial function would be reduced during an acute increase in sympathetic nervous activity 139 
(induced by mild lower-body negative pressure), and elevated during an acute decrease in 140 
sympathetic nervous activity (induced by mild lower-body positive pressure), independent of 141 
changes in peripheral hemodynamics.   142 
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Methods and Materials 143 
Ethical Approval. All experimental procedures and protocols were approved by the clinical 144 
research ethics board at the University of British Columbia and conformed to the Declaration of 145 
Helsinki. All participants provided written informed consent prior to participation in this study. 146 
This study was part of a larger research expedition conducted between September and November 147 
2016. As such, participants took part in a number of studies conducted at the University of 148 
British Columbia (Kelowna, British Columbia; 344m) and during three weeks at the Ev-K2 CNR 149 
pyramid laboratory (Khumbu Valley, Nepal, 5050m). However, the a priori, primary research 150 
questions addressed in the current paper are novel and are exclusively dealt within this study 151 
alone. 152 
 153 
Participants. Recruited participants (n=15; 1F) were normotensive (systolic blood pressure <140 154 
and diastolic pressure <90 mmHg) at rest, and completed a medical history questionnaire. The 155 
participants were non-smokers, had no previous history of cardiovascular, cerebrovascular, or 156 
respiratory diseases. During the time of testing, one participant was taking oral contraceptives 157 
(i.e. birth control), and another was taking Mesalazine. At sea-level, two participants were 158 
excluded from data analyses for the following reasons: 1) testing was terminated on one 159 
participant due to being uncomfortable in the lower-body differential chamber, thus, testing was 160 
also not continued at high-altitude in this participant, and 2) a participant was omitted from data 161 
analysis at sea-level due to inadequate brachial artery imaging. However, this participant was 162 
included in our high-altitude data analysis (n=14). In summary, out of the 15 participants 163 
recruited for the current study, 13 and 14 participants were included in our data analysis at sea-164 
level and high-altitude, respectively. In addition, cardiac output data was missing in one 165 
participant at high-altitude due to equipment malfunction. All participants arrived at the Ev-K2 166 
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CNR research facility within two days of each other, after following a similar ascent profile (7-8 167 
day trek) as described in detail elsewhere (17, 35, 55). Upon ascent, all participants avoided 168 
taking oral acetazolamide (i.e. Diamox), a carbonic anhydrase inhibitor commonly used to 169 
prevent/treat high-altitude illness. Experimentation occurred between days 11 and 14 at high-170 
altitude, and no participants had any symptoms of altitude illness during the time of testing, nor 171 
were any using aspirin, non-steroidal anti-inflammatory drugs, and phosphodiesterase-5 172 
inhibitors.  173 
 174 
Experimental Design.  175 
This study was conducted in two parts: sea-level and high-altitude investigations. Prior to each 176 
experiment, all participants abstained from exercise, alcohol, and caffeine for at least 12 hours. 177 
Additionally, participants were asked to consume a light meal at least four-hours prior to 178 
experimentation, and to keep their diet consistent between experimentation days. In order to 179 
determine whether our participants had normal healthy lung function, at sea-level we conducted 180 
a forced vital capacity (FVC) test to measure lung function, a vital capacity and inspiratory 181 
capacity maneuver to measure lung volumes, and a single breath carbon monoxide test to 182 
quantify diffusing capacity on each individual. All testing procedures were conducted in 183 
accordance with the American Thoracic Society and European Respiratory Society’s joint 184 
guidelines (36, 39). For each of these tests, participants sat within a body plethysmography box 185 
(V6200, Vmax Sensormedics, Yorba Linda, CA, USA) with a rigid upright posture and their feet 186 
flat on the ground, whilst breathing through a spirometer and bacteriological filter while wearing 187 
a nose-clip. All pulmonary function measurements were compared against population-based 188 
predictions. 189 
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 190 
Experimental protocol. After becoming comfortable within our custom lower-body differential 191 
pressure chamber (described below), participants were instructed to lie motionless in the supine 192 
position and breathe normally for 20-minutes to ensure that blood volume was comparably 193 
distributed prior to experimentation (21). At sea-level, muscle sympathetic nervous activity 194 
(MSNA) in the radial nerve was collected in a subset of participants (attempted: n=10; obtained: 195 
n=5) during the LBNP/LBPP protocol. Muscle SNA signals were obtained once the participant 196 
was instrumented while laying supine in our custom lower-body differential pressure chamber 197 
(described below). At sea-level and high-altitude, the protocol began with a five-minute eupneic 198 
breathing baseline period, after which, the pressure within the chamber was altered to one of the 199 
following: 1) -10 mmHg (LBNP trial), 2) remained unchanged at zero mmHg (control trial), or 200 
3) +10 mmHg (LBPP trial). Once adequate pressure was achieved in the lower-body differential 201 
chamber, the participant was asked to remain quiet and relaxed, and after five-minutes a brachial 202 
artery FMD was performed on the participants left arm. Once the brachial artery FMD 203 
measurement was collected, the pressure of the lower-body differential pressure chamber was 204 
alleviated and the participant was given a five-minute recovery period. The protocol was then 205 
repeated for the remaining two randomized conditions (i.e. LBNP, control, or LBPP). Before 206 
each condition, a five-minute quiet resting baseline was endured (Refer to figure 1 for a 207 
schematic of the protocol described above).  208 
Additionally, out of the five participants that we were able to obtain radial MSNA data at 209 
sea-level, MSNA signals were obtained in the peroneal nerve at rest at high-altitude in four of 210 
these participants in order to demonstrate the effects of altitude on resting MSNA. Previous work 211 
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has shown that there are no regional differences in MSNA between the radial and peroneal nerve 212 
(42).  213 
 214 
Experimental Measurements. 215 
Cardiovascular measurements. All continuously recorded cardiovascular measurements were 216 
acquired at 1000 Hz using an analog-to-digital converter (Powerlab/16SP ML 880; 217 
ADInstruments, Colorado Springs, CO, USA) interfaced with a personal computer. 218 
Commercially available software was used to analyze cardiovascular variables (LabChart V7.1, 219 
ADInstruments, Colorado Springs, CO, USA). Electrocardiogram electrodes were placed in lead 220 
II configuration (Bioamp, ML132, ADInstruments, Colorado Springs, CO, USA) to measure 221 
heart rate. Beat-by-beat arterial pressure, cardiac output, stroke volume, and total peripheral 222 
resistance was measured by finger photoplethysmography (Finometer Pro, Finapres medical 223 
systems, Amsterdam, Netherlands). Prior to baseline data collection, the Finometer was 224 
calibrated using the return-to-flow function. Mean, systolic, and diastolic arterial pressure were 225 
quantified from the raw Finometer recordings. 226 
 227 
Brachial artery imaging. With the participants left arm extended perpendicular (i.e. 90 degrees) 228 
from their body, an inflation/deflation cuff was placed on the participants left forearm, and their 229 
arm was fixed into position on a table at the level of the heart. Brachial artery image acquisition 230 
was obtained using a 10 MHz multifrequency linear array probe attached to a high-resolution 231 
ultrasound machine (15L4, Terason t3200, Burlington, MA, USA). All brachial artery images 232 
were performed by the same experienced ultrasonographer [J.C.T; performed brachial artery 233 
FMD in the following published investigations (51-53)], whom has a between day coefficient of 234 
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variation in FMD of 8.3 ± 2.1% (n=10, unpublished data). Following optimal image acquisition, 235 
and one-minute of baseline recordings, the forearm was occluded by inflating the cuff to 220 236 
mmHg for five-minutes. Recordings of diameter and velocity resumed 30-seconds prior to cuff 237 
deflation and continuously for three-minutes thereafter (48).  238 
 239 
Lower-body differential pressure chamber. Mild LBNP and LBPP was elicited using a custom‐240 
built, light-weight, portable, lower-body differential pressure chamber (designed and built by the 241 
author M.M.T). The LBNP chamber was sealed at the level of the iliac crest of each participant 242 
using stretchable waist belts. Pressure within the chamber was generated using a 120V house-243 
hold vacuum pump, and measured using a digital manometer (DigiMano 1000, 200–200IN, 244 
Netech Corporation, Farmingdale, NY, USA). The magnitude of negative pressure was 245 
manipulated using a 120‐volt input/140‐volt output variable transformer (Variac, Cleveland, OH, 246 
USA). Stable pressure of -10 mmHg LBNP or +10 mmHg LBPP were achieved within 10-15 247 
seconds after turning on the vacuum pump.  248 
 249 
Muscle sympathetic nerve activity. Recordings of MSNA were obtained by an experienced 250 
microneurographer (C.D.S and J.P.M). A tungsten microelectrode (50 mm long, 200 μm in 251 
diameter) was inserted percutaneously into the right radial nerve (at sea-level), and the right 252 
peroneal nerve (at high-altitude), using ultrasound guidance (12mHz linear array probe, GE 253 
Health Care, Canada) (10). A reference electrode was positioned subcutaneously 1–3 cm from 254 
the recording site. A suitable sympathetic nerve site was searched through manual manipulation 255 
of the tungsten microelectrode until a characteristic pulse-synchronous burst pattern was 256 
observed. Confirmation that the recorded signal represented MSNA was determined by the 257 
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absence of skin paresthesias and a signal that increased in response to voluntary apnea but not 258 
during arousal to a loud noise. Muscle sympathetic nervous activity was amplified 1,000× 259 
through a preamplifier and 100× by a variable-gain, isolated amplifier. The amplified, raw 260 
MSNA signal was band-pass filtered at a bandwidth of 700–2,000 Hz, sampled at 10,000 Hz and 261 
stored for offline analysis (LabChart V7.1, ADInstruments, Colorado Springs, CO, USA). 262 
 263 
Data Analysis 264 
Ultrasound recordings were continuously screen captured and saved for offline analysis. Blood 265 
flow analysis of the brachial artery was performed using automated edge-detection and wall 266 
tracking software, which allows for the integration of synchronous diameter and velocity 267 
measurements to continuously determine flow, shear, diameter and velocity at 30-Hz, while 268 
minimizing investigator bias (56). Antegrade, retrograde, and mean shear rates were calculated 269 
as four times the mean blood velocity, divided by vessel diameter and the oscillatory shear index 270 
as |retrograde shear rate| / (|antegrade shear rate| + |retrograde shear rate|). The FMD was 271 
calculated as the percent increase in vessel diameter from resting baseline diameter to peak 272 
diameter following cuff release, where baseline and peak diameters were automatically detected 273 
from the continuous data described above.  274 
 Muscle sympathetic nervous activity was analyzed using peak analysis software 275 
(LabChart V7.1, ADInstruments, Colorado Springs, CO, USA). Two minutes of MSNA data was 276 
averaged immediately prior to the end of each LBNP, control, and LBPP trial, and was expressed 277 
as the frequency of MSNA bursts per minute, and incidence per 100 heart beats.   278 
 279 
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Adjusted flow-mediated dilatation. The effects condition (i.e. LBNP, control, and LBPP) were 280 
analyzed within and between sea-level and high-altitude for brachial artery FMD. To determine 281 
if our FMD results were altered due to changes in baseline arterial diameter and/or shear rate 282 
area under the curve (SRAUC) in response to forearm cuff release, we included these variables 283 
as covariates in a logarithmic-linked generalized linear model, where FMD was the dependent 284 
variable. This approach has been used to account for any changes in FMD that may be related to 285 
differences in baseline diameter or shear rate between conditions (i.e. time and condition) (2). 286 
 287 
Statistics 288 
All statistical analyses were performed using SigmaStat V13 (Systat, Chicago, IL, USA), and 289 
were reported as mean  SEM. Statistical significance was set at P<0.05. Paired t-tests were used 290 
to detect changes in cardiovascular variables between baseline and during the brachial artery 291 
FMD during LBNP, control, and LBPP at both sea-level and high-altitude (see table 1). One-way 292 
and two-repeated measures analysis of variance were used to detect any differences in brachial 293 
artery variables (see table 2, figure 2, and figure 5). One-way repeated measures analysis of 294 
variance was used to detect any differences in MSNA between LBNP, control, and LBPP trials  295 
at sea-level (see figure 3), and paired t-tests were used to assess any differences in MSNA 296 
between sea-level and high-altitude at rest (see figure 4). When significant F-ratios were 297 
detected, post-hoc comparisons were made using Bonferonni post hoc test for pair-wise 298 
comparisons.  299 
 300 
  301 
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Results 302 
Participants 303 
The participants included in the sea-level (n=13) and high-altitude (n=14) protocol data analysis 304 
had a mean  SEM age of 27.2  1.7 years, height of 179.5  1.7 cm, and weight of 74.4  2.5 305 
kg. Participants had normal pulmonary health with an FVC of 5.5  0.1 L (104.3  2.4% of 306 
predicted), forced expiratory volume in one-second (FEV1) of 4.3  0.1 L (95.5  3.3% of 307 
predicted), FEV1/FVC of 78.3  1.1, total lung capacity of 6.8  0.2 L (98.5  2.3% of 308 
predicted), and had a diffusing capacity of the lung for carbon monoxide of 33.1  1.6 309 
ml/min/mmHg (93.1  3.9% of predicted). Recruited participants did not demonstrate any signs 310 
of small nor large airway obstruction characterized by an irregular expiratory flow tracing during 311 
the FVC maneuver.  312 
 313 
Endothelial function between sea-level and high-altitude. 314 
At high-altitude, absolute brachial artery FMD was reduced compared to sea-level by 0.10 ± 0.05 315 
mm during the LBNP trial; 0.08 ± 0.05 mm during the control trial, and; 0.07 ± 0.04 mm during 316 
the LBPP trial (main effect: P=0.024; see figure 2). Additionally, there was no condition effect of 317 
LBNP, control, LBPP (P=0.243), nor interaction effect (P=0.835). Similarly, although relative 318 
brachial artery FMD was reduced at high-altitude compared to sea-level, this effect marginally 319 
missed our statistical significant criteria of P<0.05 (P=0.061). No differences were detected in 320 
relative brachial artery FMD for condition (P=0.343), nor interaction (P=0.856; see figure 2). In 321 
addition, when taking into account SRAUC and changes in baseline brachial artery diameter 322 
between sea-level and high-altitude, our results for brachial FMD were the same with a main 323 
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effect between sea-level and high-altitude (P=0.008), and no differences found for condition 324 
(P=0.250), nor interaction (P=0.693).  325 
 326 
Muscle sympathetic nervous activity at sea-level and high-altitude. 327 
Muscle sympathetic nervous activity was collected in a subset of participants (n=5) at sea-level 328 
(see figure 3). During the -10 mmHg LBNP trial, MSNA bursts per minute was elevated by 59.1 329 
± 25.2% compared to control (P=0.007), and by 140.1 ± 10.6% compared to the +10 mmHg 330 
LBPP trial (P=0.047). No differences were found between LBPP and the control trial with our 331 
one-way repeated measures analysis of variance; however, when comparing MSNA bursts per 332 
minute using a paired t-test, MSNA was significantly reduced by 39.2 ± 12.3% (P=0.03; see 333 
figure 3) during the LBPP trial. Similarly, MSNA burst incidence (per 100 heart beats) was 334 
elevated by 61.5 ± 25.9% compared to control (P=0.005), and by 131.9 ± 11.7% compared to the 335 
+10 mmHg LBPP trial (P=0.03). When comparing MSNA burst incidence using a paired t-test 336 
between LBPP and control trials, MSNA was significantly reduced by 35.1 ± 13.2% (P=0.04; see 337 
figure 3). 338 
 Out of the five participants that MSNA recordings were obtained at sea-level, we were 339 
able to obtain peroneal MSNA signals at rest in four of these participants at high-altitude (see 340 
figure 4). At high-altitude, MSNA bursts per minute was elevated compared to sea-level by 98.2 341 
± 39.5% (P=0.03), and although MSNA burst incidence was also higher at high-altitude 342 
compared to sea-level by 72.0 ± 35.2%, this elevation did not reach statistical significance 343 
(P=0.05; see figure 4).  344 
 345 
Cardiovascular variables during LBNP and LBPP. 346 
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Sea-level: As expected, no change was present in HR, SV, CO, and TPR between baseline and 347 
FMD during LBNP (P=0.367, P=0.847, P=0.320, and P=0.614, respectively), control (P=0.854, 348 
P=0.155, P=0.472, and P=0.892, respectively), and LBPP (P=0.534, P=0.218, P=0.238, and 349 
P=0.785, respectively). Mean arterial pressure also remained unchanged from baseline during the 350 
LBNP and control trials (P=0.243 and P=0.257, respectively); however, it was elevated by 4.2 ± 351 
1.2 mmHg during the LBPP trial (P=0.003; see table 1).   352 
 353 
High-altitude: At high-altitude, HR, SV, CO, and TPR were the same between baseline and FMD 354 
during LBNP (P=0.703, P=0.677, P=0.992, and P=0.063, respectively), control (P=0.054, 355 
P=0.233, P=0.313, and P=0.453, respectively), and LBPP (P=0.201, P=0.355, P=867, and 356 
P=0.845, respectively). Mean arterial pressure was unchanged during the LBNP and control trial 357 
before and after brachial FMD (P=0.099 and P=0.171, respectively). In contrast, it was slightly 358 
elevated by 4.5 ± 0.9 mmHg during LBPP (P<0.001; see table 1).  359 
 360 
Brachial artery responses during LBNP and LBPP.  361 
Sea-level: Brachial artery diameter, blood velocity, blood flow, and vascular resistance were the 362 
same between LBNP, control, and LBPP trials (main effects: P=0.422, P=0.384, P=0.985, and 363 
P=0.867 respectively). Additionally, brachial mean, antegrade, and retrograde shear rates, and 364 
the oscillatory shear index were not different between LBNP, control, and LBPP (main effects: 365 
P=0.928, P=0.928, P=0.891, and P=0.919, respectively; see table 2).  366 
 367 
High-altitude: No differences were detected in brachial artery diameter, blood velocity, blood 368 
flow, and vascular resistance was the same between LBNP, control, and LBPP trials (main 369 
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effects: P=0.993, P=0.224, P=0.405, and P=0.235, respectively). Additionally, brachial mean, 370 
antegrade, and retrograde shear rates, and the oscillatory shear index were not different between 371 
LBNP, control, and LBPP (main effects: P=0.304, P=0.563, P=0.119, and P=0.186, respectively; 372 
see table 2). 373 
 374 
Endothelial function during LBNP and LBPP. 375 
Sea-level: No difference was detected in SRAUC to peak diameter between LBNP, control, and 376 
LBPP trials (main effect: P=0.995). At sea-level, one participant was excluded from mean data 377 
analysis due to low-quality video files. Brachial artery FMD (n=13) did not change between 378 
LBNP, control, and LBPP (main effect: P=0.448).  379 
 380 
High-altitude: There were no differences detected for SRAUC between LBNP, control, and 381 
LBPP trials (main effect: P=0.825) during the hypobaric hypoxia trial. Brachial artery FMD 382 
(n=14) did not change between LBNP, control, and LBPP trials (main effect: 0.537; see figure 383 
5).  384 
  385 
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Discussion 386 
Using a novel, and randomized experimental design, we examined the effect of acute alterations 387 
of SNA using mild LBNP and LBPP on brachial artery endothelial function at both sea-level 388 
(344m) and high-altitude (5050m). Our main findings were the following: 1) in support of 389 
previous studies, MSNA was elevated, and brachial artery endothelial function was reduced at 390 
high-altitude compared to sea-level after active ascent to 5050m, and 2) despite acutely 391 
increasing SNA with LBNP, and decreasing SNA with LBPP, we demonstrated that brachial 392 
artery endothelial function remained unchanged at sea-level and high-altitude. Our data indicates 393 
that mild and acute changes in SNA, at least in the absence of alterations in systemic 394 
hemodynamics, does not influence endothelial function.  395 
 396 
Effect of high-altitude on endothelial function 397 
The effects of high-altitude acclimatization on endothelial function, as assessed via brachial 398 
FMD, has been studied previously. These studies have reported contradictory results such as 399 
reduced FMD (3, 35), or no change in FMD upon acclimatization to high-altitude (5, 6, 52, 53). 400 
Despite the disparities between these studies, elevations in SNA is proposed to have a profound 401 
effect on brachial FMD (26, 53). After four-weeks of acclimatization to high-altitude (5260m), 402 
MSNA has been shown to be elevated by ~200% (23). The current study confirms these previous 403 
findings as we have demonstrated in four participants that MSNA was substantially elevated at 404 
rest after acclimatization to 5050m (see figure 4). This increase in SNA and total peripheral 405 
resistance is likely responsible for the substantial decrease in brachial artery blood flow observed 406 
at high-altitude (14).  407 
An alternative explanation for the reported differences between these high-altitude FMD 408 
studies may lie within the mode of travel to high-altitude, and the severity of altitude exposure. 409 
 by 10.220.33.2 on Septem
ber 20, 2017
http://jap.physiology.org/
D
ow
nloaded from
 
For example, the studies that have reported a decrease in brachial FMD took place after 5-10 410 
days of trekking at high-altitude [4200m, (3); and 5050m, (35)]. In contrast, the studies that have 411 
reported no change in endothelial function arrived at a more moderate altitude passively by 412 
automobile [at 3800m (52, 53)], or cable car [at 3842m (5, 6)]. The high-altitude arm of the 413 
current study involved trekking ascent to 5050m over 7-8 days, and in support of our hypothesis 414 
and previous reports (3, 35), we found that brachial artery endothelial function was reduced at 415 
high-altitude compared to sea-level. This reduction may be due to long-term elevations in 416 
sympathetic nervous activity or marked elevations in oxidative stress, or both. 417 
 418 
Altering sympathetic nervous activity non-invasively with lower-body negative and lower-body 419 
positive pressure.  420 
There have been several investigations on the role of the SNA on endothelial function assessed 421 
by brachial FMD at sea-level (1, 16, 26, 47, 53); however, none of these studies have 422 
concurrently measured SNA using microneurography. Existing literature indicates that our mode 423 
of altering SNA (i.e. mild LBNP and LBPP) could provide a useful model to evaluate the role of 424 
SNA on endothelial function, assuming that this methodology significantly alters SNA 425 
independent of hemodynamics (9, 18, 38, 41-43). For the current project we developed a novel, 426 
light-weight, purpose built lower-body differential pressure chamber and measured its 427 
effectiveness of altering radial MSNA, which is representative of global MSNA (42), during our 428 
sea level trial (n=5). Our radial MSNA data indicates that SNA was elevated during LBNP and 429 
reduced during LBPP (see figure 3). Here, we established an effective methodological approach, 430 
to non-invasively increase and decrease SNA largely independent of systemic hemodynamics, 431 
however, the observed alterations in SNA failed to evoke a change in brachial artery resistance 432 
(see table 2) – a clear indicator of vascular constraint. Thus, since vascular constraint was not 433 
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significantly altered during acute and mild LBNP/LBPP, it is unclear if the experimental design 434 
in its current form is effective when investigating the effects of SNA on endothelial function. 435 
Future studies using a similar LBNP/LBPP experimental model should consider a longer 436 
duration of stimulus (i.e. LBNP or LBPP), which may be more effective in altering peripheral 437 
vascular resistance. 438 
 439 
Effect of sympathetic nervous activity on endothelial function at sea-level. 440 
Although there have been several reports of SNA influencing endothelial function (1, 16, 26, 48, 441 
53), it has been suggested that the method of altering SNA may yield different results (16). For 442 
example, Dyson et al. (16) investigated the role of SNA (via epinephrine and norepinephrine 443 
spillover) on brachial artery endothelial function, and discovered that the cold pressor test was 444 
the only modality that reduced brachial artery FMD. Interestingly, Dyson et al. (16) found that 445 
LBNP increased SNA, but it had no effect on brachial artery endothelial function, which 446 
contrasts other studies that have found that LBNP reduces brachial artery endothelial function 447 
(26, 47). The first report of LBNP significantly reducing brachial artery endothelial function was 448 
by Hijmering et al. (26). Here, they discovered that the reduction in brachial artery endothelial 449 
function was mediated through a α1-adrenergic pathway as endothelial function was restored 450 
during LBNP after administration phentolamine. This finding was supported by two recent 451 
studies that used exercise as a method of increasing SNA (1, 53). Hijmering et al. (26) also 452 
suggested that the observed reduction in brachial artery endothelial function could be directly 453 
due to SNA, or indirectly via other mechanisms during LBNP such as altered hemodynamics 454 
(e.g. increases in retrograde shear stress). Thijssen et al. (47) attempted to address this question 455 
by using a local heating stimulus (to one arm) during LBNP in order to abolish the increase in 456 
retrograde shear stress typically observed during moderate-to-severe magnitudes of LBNP (41, 457 
 by 10.220.33.2 on Septem
ber 20, 2017
http://jap.physiology.org/
D
ow
nloaded from
 
47). Their findings revealed that brachial artery endothelial function was restored after the heat 458 
stimulus was applied and retrograde shear rate was reduced (47). However, altered 459 
hemodynamics (e.g. increased heart rate and reduced stroke volume) during LBNP were still 460 
present (47), and these physiological changes can directly affect endothelial function [reviewed 461 
in (22)].  462 
The current study attempts to address this research question by manipulating SNA largely 463 
independent of changes in hemodynamics. This is the first study to investigate the role of SNA 464 
on endothelial function by increasing and decreasing SNA using LBNP and LBPP, respectively, 465 
findings confirmed (at sea-level) via microneurography. In contrast to our hypothesis, we did not 466 
observe any change in brachial artery endothelial function during LBNP - a finding that is 467 
consistent with at least one previous study (16), but opposes other reports (26, 47). It is possible 468 
that we did not increase SNA activity enough in order to influence endothelial function; 469 
however, the experimental design may be more important than the magnitude of SNA increase. 470 
For example, Dyson et al. (16) demonstrated that the only intervention that altered endothelial 471 
function during elevated SNA was not the intervention that evoked the largest SNA response. 472 
Interestingly, acute hypoxia (FIO2 = 0.11) has shown to reduce brachial artery endothelial 473 
function after 60-minutes (35), and this severity of hypoxia has been shown to increase SNA to 474 
approximately the same extent as our -10 mmHg LBNP stimulus (13). Additionally, it is possible 475 
that the current experimental design was too short in duration to evoke a change in vascular 476 
resistance and endothelial function. For example, a recent study demonstrated that 30-minutes of 477 
sustained moderate exercise reduced endothelial function via an α1-adrenergic pathway; 478 
however, a ~10-minute maximal exercise test did not evoke the same results (53). Nevertheless, 479 
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our data indicates that acute and mild SNA activation and deactivation via LBNP and LBPP does 480 
not alter brachial artery endothelial function.  481 
 482 
Effect of sympathetic nervous activity on endothelial function at high-altitude. 483 
Lower-body negative pressure has been previously used to measure orthostatic tolerance in high-484 
altitude Andean natives at high-altitude [4338m; (7)]; however, this is the first investigation to 485 
use LBNP above 5000m where MSNA is markedly elevated (see figure 4), in addition, this is the 486 
first study to use LBPP at high-altitude. Our research group has published the only other report 487 
investigating the role of SNA on endothelial function at high-altitude (53). Using moderate-488 
intensity exercise to increase SNA, we found that brachial artery endothelial function is not 489 
reduced at high-altitude, indicating that after acclimatization to high-altitude neurovascular 490 
control may be altered (53). It is also unknown whether our previously reported findings were 491 
unique to exercise, and hence potentially, a different strategy to alter SNA may yield different 492 
results (16). Additionally, SNA stimulus (e.g. exercise) has been shown to be augmented with 493 
cycling exercise during hypoxia (30) – meaning that the alteration in SNA via LBNP and LBPP 494 
could be exacerbated at high-altitude, leading to a more pronounced effect on endothelial 495 
function. Therefore, we hypothesized that altering SNA using LBNP and LBPP would result in a 496 
decrease and increase in brachial artery endothelial function, respectively. To our surprise, 497 
similar to our sea-level data, we found that LBNP and LBPP did not change endothelial function 498 
at high-altitude. However, the lack of effect of LBNP and LBPP on endothelial function at high-499 
altitude could be also be due to similar methodological reasoning outlined above: (a) our mode 500 
of altering SNA does not alter brachial endothelial function, and/or (b) the duration of SNA 501 
activation/deactivation was not long enough to elicit a change in endothelial function.  502 
 503 
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Methodological considerations 504 
The degree of LBPP chosen for the current research project (i.e. +10 mmHg) was determined 505 
based on previous literature, which reported no changes of MAP (18, 38). However, during our 506 
LBPP trials at sea-level and high-altitude, LBPP elevated MAP elevated by ~4-5 mmHg, 507 
potentially due to LBPP associated transient fluid shifts. This result was likely not due to 508 
measurement drift from our continuous blood pressure monitor (i.e. finometer), since LBPP 509 
selectively increased MAP in both sea-level and high-altitude protocols, and the finometer was 510 
carefully calibrated before each trail. Changes in blood pressure could have a direct effect on 511 
brachial FMD (22); however, since mild LBNP and LBPP did not alter our other physiological 512 
variables (especially shear patterns), we feel that the small change in blood pressure is likely 513 
trivial. Although the recovery time between LBNP, control, and LBPP trials (5 minutes) was 514 
acute, previous data (18, 43), and our data indicates that participants research steady state 515 
following this short recovery period. Another consideration is that due to methodological 516 
constraints at high-altitude, we were unable to measure SNA via microneurography, therefore, 517 
the absolute effect of LBNP and LBPP on SNA at high-altitude is unknown. Additionally, it is 518 
important to consider that neurovascular transduction may be different at high-altitude compared 519 
to sea-level, but this is still under debate as there is evidence that neurovascular transduction is 520 
reduced (34), or increased (46), with exposure to hypoxia. We did, however, obtain MSNA 521 
recordings in the peroneal nerve at rest in a subset of participants (n=4) at both sea-level and 522 
high-altitude. We acknowledge that our MSNA data collected at sea-level and high-altitude were 523 
in the radial and peroneal nerves, respectively, but it has been previously demonstrated that 524 
MSNA does not differ between these two nerves during mild lower-body negative pressure and 525 
are both a reflection of global MSNA (42). Although our MSNA sample size was small, we still 526 
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detected statistical significance between LBNP and LBPP trials, which were recorded using a 527 
within subject design at sea-level.  528 
Our experimental design warrants further comment. Our LBNP/LBPP methodological 529 
approach to bi-directionally alter SNA proved successful; however, the current study design 530 
failed to change brachial artery vascular resistance. We view our study design as a “double-531 
edged sword”, as it altered SNA largely independently of hemodynamics, yet it was not a potent 532 
enough stimulus to alter brachial artery resistance, making it unclear if our study design is 533 
appropriate to investigate the effects of SNA on peripheral vascular function. Lastly, menstrual 534 
cycle was not taken into consideration for our one female participant, and previous evidence 535 
indicates that brachial artery FMD changes throughout the menstrual cycle (25). However, our 536 
primary research objective was to look at the within-day comparison of brachial FMD between 537 
LBNP, control, and LBPP trials, therefore, the results of these data should not be affected by 538 
differences in menstrual cycle between sea-level and high-altitude. Importantly, changes in blood 539 
viscosity between sea-level and high-altitude was not taken into account when analyzing brachial 540 
artery FMD. However, a reduction in brachial artery FMD was still observed at high-altitude, 541 
even though hematocrit, thus shear stress, was likely higher during cuff release.  542 
 543 
Conclusion 544 
We used a novel experimental approach to investigate the relationship between sympathetic 545 
nervous activity and endothelial function by using mild lower-body negative pressure and lower-546 
body positive pressure at both sea-level and high-altitude. We demonstrated for the first time 547 
using a novel, experimental design, that altering sympathetic nervous activity largely 548 
independent of hemodynamics (e.g. heart rate, stroke volume, shear stress) had no effect on 549 
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brachial artery endothelial function. These findings suggest that brachial artery endothelial 550 
function may not be directly mediated through sympathetic nervous activity associated vascular 551 
constraint. Together, our findings have implications for better understanding the consequential 552 
impact of sympathetic nervous activity on vascular function.  553 
  554 
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List of Tables 741 
Table 1: Cardiovascular variables at baseline, and during lower-body differential pressure at sea-level and high-altitude. 742 
 Sea-level High-altitude 
LBNP Control LBPP LBNP Control LBPP 
HR 
(bpm) 
BL 55.7 ± 3.0 54.9 ± 3.3 55.5 ± 3.2 61.4 ± 3.3 64.0 ± 4.1 61.9 ± 2.6 
FMD 54.9 ± 3.1 54.7 ± 2.8 55.1 ± 3.1 62.0 ± 3.4 59.6 ± 2.9 61.3 ± 3.2 
SV 
(ml) 
BL 99.8 ± 4.7 101.1 ± 3.8  99.9 ± 5.3 78.7 ± 3.4  79.1 ± 5.2 74.8 ± 4.3 
FMD 99.4 ± 4.7 104 ± 4.2 103.3 ± 5.5 77.8 ±4.4 82.4 ± 4.6 78.1 ± 3.9 
CO 
(l min
-1
) 
BL 5.6 ± 0.5 5.6 ± 0.5 5.5 ± 0.6 4.7 ± 0.3 4.8 ± 0.4 4.5 ± 0.3 
FMD 5.5 ± 0.4 5.7 ± 0.5 5.7 ± 0.6 4.7 ± 0.3 4.8 ± 0.3 4.6 ± 0.3 
MAP  
(mmHg) 
BL 92.0 ± 1.9 91.1 ± 1.7 92.6 ± 2.2 99.3 ± 1.6 103.3 ± 2.2 102.5 ± 1.8 
FMD 93.8 ± 3.0 92.2 ± 1.8 96.8 ± 2.3* 101.7 ± 1.6 104.4 ± 1.6 107.0 ± 2.2* 
TPR 
[dyn s/cm
5
] 
BL 1350.1 ± 106.7 1305.6 ± 94.5 1365.9 ± 96.3 1747.2 ± 125.5 1767.9 ± 135.6 1880.4 ± 132.6 
FMD 1370.0 ± 87.5 1309.6 ± 90.5 1352.0 ± 107.2 1822.3 ± 147.2 1752.0 ± 108.3 1863.1 ± 105.9 
SpO2 
(%) 
BL       83.3 ± 0.7 83.7 ± 0.9* 83.4 ± 0.9 
FMD       82.7 ± 0.7 81.6 ± 0.6 82.2 ± 0.8 
Definition of Abbreviations: HR, heart rate; SV, stroke volume; CO, cardiac output; MAP, mean arterial pressure; TPR, total 743 
peripheral resistance; SpO2, peripheral capillary oxygen saturation. *P<0.05, BL vs FMD.  744 
  745 
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Table 2: Brachial artery variables during the control and lower-body differential pressure trials at sea-level and high-altitude. 746 
 747 
 748 
 749 
 750 
 751 
 752 
 753 
 754 
 755 
 756 
 757 
 758 
 759 
Definition of Abbreviations: BA, brachial artery. 760 
 Sea-level High-altitude 
LBNP Control LBPP LBNP Control LBPP 
BA diameter 
(mm) 
4.6 ± 0.1 4.6 ± 0.1 4.7 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 
BA velocity 
(cm s
-1
) 
14.0 ± 3.0 13.7 ± 2.7 14.4 ± 3.7 5.4 ± 1.0 6.3 ± 1.2 6.5 ± 1.2 
BA flow 
(ml min
-1
) 
147.0 ± 33.3 142.7 ± 30.6 146.0 ± 35.5 46.5 ± 9.5 53.1 ± 11.1 54.5 ± 11.4 
BA resistance 
[mm Hg (ml min
-1
)
-1
] 
1.1 ± 0.3 1.0 ± 0.2 1.1 ± 0.2 3.0 ± 0.5 2.9 ± 0.5 2.7 ± 0.4 
BA mean shear 
(s
-1
) 
127.5 ± 27.4 136.1 ± 37.2 125.6 ± 33.4 50.0 ± 9.1 59.6 ± 10.9 62.4 ± 11.1 
BA antegrade shear 
(s
-1
) 
136.5 ± 26.0  145.6 ± 36.0 135.7 ± 32.0 70.7 ± 8.2  79.0 ± 9.6 77.1 ± 10.8 
BA retrograde shear 
(s
-1
) 
9.0 ± 2.2 9.5 ± 2.5 10.2 ± 3.6 20.6 ± 4.3 19.5 ± 4.0 14.8 ± 2.1 
BA oscillatory shear 
(s
-1
) 
0.09 ± 0.02 0.10 ±0.03 0.10 ± 0.03 0.23 ± 0.03 0.21 ± 0.03 0.18 ± 0.02 
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Figure Legends 761 
Figure 1: A schematic representation of the experimental protocol conducted at sea-level 762 
and high-altitude, and raw MSNA neurogram in two participants. After 20-minutes of 763 
supine rest, the protocol began with a five-minute eupneic breathing baseline period, after which, 764 
the pressure within the chamber was altered to one of the following: 1) -10 mmHg (LBNP trial), 765 
2) remained unchanged at zero mmHg (control trial), or 3) +10 mmHg (LBPP trial). Once 766 
pressure was achieved, and maintained for five-minutes, a brachial artery FMD was performed 767 
on the participants left arm. Once the brachial artery FMD measurement was collected, the 768 
pressure of the lower-body differential pressure chamber was alleviated and the participant was 769 
given a five-minute recovery period. The protocol was then repeated for the remaining two 770 
randomized conditions (i.e. LBNP, control, or LBPP). Before each condition, a five-minute quiet 771 
resting baseline was endured. 772 
Figure 2: A comparison of absolute and relative brachial artery flow-mediated dilation 773 
response between sea-level and high-altitude. These data highlight that absolute and relative 774 
brachial artery flow mediated dilation remained unchanged between sea-level and high-altitude 775 
within LBNP, control, and LBPP trials. Taking into account changes in baseline brachial artery 776 
diameter and SRAUC between sea-level and high-altitude, we found that relative endothelial 777 
function is still reduced at high-altitude compared to sea-level (P=0.008; see results section) 778 
Figure 3: Muscle sympathetic nervous activity during LBNP, control, and LBPP trials at 779 
sea-level. Individual data of MSNA burst frequency (Panel A; bursts/minute), and burst 780 
incidence (Panel B; bursts per 100 heart beats) during LBNP (n=5), control (n=5), and LBPP 781 
(n=4) at sea-level. These findings illustrate a significant difference in MSNA between LBNP and 782 
LBPP. The gray line on the figure depicts the average between individuals during each trial. 783 
Figure 4: Muscle sympathetic nervous activity at rest between sea-level and high-altitude. 784 
Individual data of MSNA burst frequency (Panel A; bursts/minute), and burst incidence (Panel 785 
B; bursts per 100 heart beats) between sea-level and high-altitude (n=4). These findings illustrate 786 
MSNA was significantly elevated in each individual at high-altitude, compared to sea-level. The 787 
gray line on the figure depicts the average between individuals during each trial. 788 
Figure 5: Brachial artery shear rate and diameter response to forearm cuff release at sea-789 
level and high-altitude. Panels A and B represent mean data ±SEM for shear rate response 790 
during brachial artery FMD during LBNP, control, and LBPP trials at sea-level (n=13) and high-791 
altitude (n=14). Panels C and D represent mean data ±SEM for relative FMD during LBNP, 792 
control, and LBPP trials at sea-level (n=13) and high-altitude (n=14). These findings 793 
demonstrate that LBNP nor LBPP had no effect on brachial artery FMD, despite altering MSNA. 794 
The gray line on the figure depicts the average between individuals during each trial. 795 
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Figure 3 
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Figure 4 
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Figure 5 
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